BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 16762631)

  • 1. Hepatic iron overload induces hepatocellular carcinoma in transgenic mice expressing the hepatitis C virus polyprotein.
    Furutani T; Hino K; Okuda M; Gondo T; Nishina S; Kitase A; Korenaga M; Xiao SY; Weinman SA; Lemon SM; Sakaida I; Okita K
    Gastroenterology; 2006 Jun; 130(7):2087-98. PubMed ID: 16762631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus protein and iron overload induce hepatic steatosis through the unfolded protein response in mice.
    Nishina S; Korenaga M; Hidaka I; Shinozaki A; Sakai A; Gondo T; Tabuchi M; Kishi F; Hino K
    Liver Int; 2010 May; 30(5):683-92. PubMed ID: 20214734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus-induced reactive oxygen species raise hepatic iron level in mice by reducing hepcidin transcription.
    Nishina S; Hino K; Korenaga M; Vecchi C; Pietrangelo A; Mizukami Y; Furutani T; Sakai A; Okuda M; Hidaka I; Okita K; Sakaida I
    Gastroenterology; 2008 Jan; 134(1):226-38. PubMed ID: 18166355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis.
    Moriya K; Nakagawa K; Santa T; Shintani Y; Fujie H; Miyoshi H; Tsutsumi T; Miyazawa T; Ishibashi K; Horie T; Imai K; Todoroki T; Kimura S; Koike K
    Cancer Res; 2001 Jun; 61(11):4365-70. PubMed ID: 11389061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice.
    Moriya K; Fujie H; Shintani Y; Yotsuyanagi H; Tsutsumi T; Ishibashi K; Matsuura Y; Kimura S; Miyamura T; Koike K
    Nat Med; 1998 Sep; 4(9):1065-7. PubMed ID: 9734402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PPARalpha activation is essential for HCV core protein-induced hepatic steatosis and hepatocellular carcinoma in mice.
    Tanaka N; Moriya K; Kiyosawa K; Koike K; Gonzalez FJ; Aoyama T
    J Clin Invest; 2008 Feb; 118(2):683-94. PubMed ID: 18188449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant transformation of the cultured human hepatocytes induced by hepatitis C virus core protein.
    Shan Y; Chen XG; Huang B; Hu AB; Xiao D; Guo ZM
    Liver Int; 2005 Feb; 25(1):141-7. PubMed ID: 15698411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis.
    Pekow JR; Bhan AK; Zheng H; Chung RT
    Cancer; 2007 Jun; 109(12):2490-6. PubMed ID: 17487861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stronger Neo-Minophagen C, a glycyrrhizin-containing preparation, protects liver against carbon tetrachloride-induced oxidative stress in transgenic mice expressing the hepatitis C virus polyprotein.
    Hidaka I; Hino K; Korenaga M; Gondo T; Nishina S; Ando M; Okuda M; Sakaida I
    Liver Int; 2007 Aug; 27(6):845-53. PubMed ID: 17617128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron overload is associated with hepatic oxidative damage to DNA in nonalcoholic steatohepatitis.
    Fujita N; Miyachi H; Tanaka H; Takeo M; Nakagawa N; Kobayashi Y; Iwasa M; Watanabe S; Takei Y
    Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):424-32. PubMed ID: 19190144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus contributes to hepatocarcinogenesis by modulating metabolic and intracellular signaling pathways.
    Koike K
    J Gastroenterol Hepatol; 2007 Jun; 22 Suppl 1():S108-11. PubMed ID: 17567457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron, HCV, and liver cancer: hard metal setting the pace?
    Mueller S; Afdhal NH; Schuppan D
    Gastroenterology; 2006 Jun; 130(7):2229-34. PubMed ID: 16762645
    [No Abstract]   [Full Text] [Related]  

  • 13. Iron overload promotes Cyclin D1 expression and alters cell cycle in mouse hepatocytes.
    Troadec MB; Courselaud B; Détivaud L; Haziza-Pigeon C; Leroyer P; Brissot P; Loréal O
    J Hepatol; 2006 Feb; 44(2):391-9. PubMed ID: 16229922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic analysis of hepatic iron overload in mice suggests dysregulation of urea cycle, impairment of fatty acid oxidation, and changes in the methylation cycle.
    Petrak J; Myslivcova D; Man P; Cmejla R; Cmejlova J; Vyoral D; Elleder M; Vulpe CD
    Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1490-8. PubMed ID: 17307722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron overload in patients with chronic hepatitis C virus infection: clinical and histological study.
    Silva IS; Perez RM; Oliveira PV; Cantagalo MI; Dantas E; Sisti C; Figueiredo-Mendes C; Lanzoni VP; Silva A; Ferraz ML
    J Gastroenterol Hepatol; 2005 Feb; 20(2):243-8. PubMed ID: 15683427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic iron overload and hepatocellular carcinoma.
    Kew MC
    Cancer Lett; 2009 Dec; 286(1):38-43. PubMed ID: 19081672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver microsomal triglyceride transfer protein is involved in hepatitis C liver steatosis.
    Mirandola S; Realdon S; Iqbal J; Gerotto M; Dal Pero F; Bortoletto G; Marcolongo M; Vario A; Datz C; Hussain MM; Alberti A
    Gastroenterology; 2006 May; 130(6):1661-9. PubMed ID: 16697730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocyte proliferative activity in chronic liver damage as assessed by the monoclonal antibody MIB1 Ki67 in archival material: the role of etiology, disease activity, iron, and lipid peroxidation.
    Farinati F; Cardin R; D'Errico A; De Maria N; Naccarato R; Cecchetto A; Grigioni W
    Hepatology; 1996 Jun; 23(6):1468-75. PubMed ID: 8675166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus acts as a tumor accelerator by blocking apoptosis in a mouse model of hepatocarcinogenesis.
    Kamegaya Y; Hiasa Y; Zukerberg L; Fowler N; Blackard JT; Lin W; Choe WH; Schmidt EV; Chung RT
    Hepatology; 2005 Mar; 41(3):660-7. PubMed ID: 15723444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normalization of elevated hepatic 8-hydroxy-2'-deoxyguanosine levels in chronic hepatitis C patients by phlebotomy and low iron diet.
    Kato J; Kobune M; Nakamura T; Kuroiwa G; Takada K; Takimoto R; Sato Y; Fujikawa K; Takahashi M; Takayama T; Ikeda T; Niitsu Y
    Cancer Res; 2001 Dec; 61(24):8697-702. PubMed ID: 11751387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.